51
|
Hou S, Hao X, Li J, Weng S, Wang J, Zhao T, Li W, Hu X, Deng B, Gu J, Hang Q. TM4SF1 promotes esophageal squamous cell carcinoma metastasis by interacting with integrin α6. Cell Death Dis 2022; 13:609. [PMID: 35835740 PMCID: PMC9283456 DOI: 10.1038/s41419-022-05067-2] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2021] [Revised: 07/03/2022] [Accepted: 07/04/2022] [Indexed: 01/21/2023]
Abstract
Transmembrane-4 L-six family member-1 (TM4SF1) is a member of the L6 family and functions as a signal transducer to regulate tumor cell behaviors. However, the function and mechanism of TM4SF1 in esophageal squamous cell carcinoma (ESCC) metastasis remains unclear. Here, we find that TM4SF1 expression is increased and positively correlated with clinical TNM stage, N classification, differentiation, tumor size, and poor prognosis in ESCC patients. Interestingly, we demonstrate that TM4SF1 promotes ESCC cell adhesion, spreading, migration, and invasion, but not cell proliferation, in a laminin-dependent manner by interacting with integrin α6. Mechanistically, the TM4SF1/integrin α6/FAK axis signal pathway mediates cell migration under laminin-coating condition. Inhibiting FAK or knocking down TM4SF1 can attenuate TM4SF1-mediated cell migration and lung metastasis. Clinically, the TM4SF1/integrin α6/FAK axis positively correlates with ESCC. Altogether, these findings reveal a new mechanism of TM4SF1 in promoting ESCC metastasis via binding to integrin α6 and suggest that the cross-talk between TM4SF1 and integrin α6 may serve as a therapeutic target for ESCC.
Collapse
|
52
|
Deng B, Guo F, Duan N, Yang S, Tian H, Sun B. A Solvatochromic Fluorescent Probe for Solvent Polarity Detection Using a Smartphone. ChemistrySelect 2022. [DOI: 10.1002/slct.202200766] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
53
|
Deng B, Feng J, Duan N, Yang S, Tian H, Sun B. A novel fluorescence probe for the detection of water content in organic solvents and the distinction between deuterated and nondeuterated reagents. LUMINESCENCE 2022; 37:1427-1435. [PMID: 35724328 DOI: 10.1002/bio.4314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2022] [Revised: 06/10/2022] [Accepted: 06/16/2022] [Indexed: 11/10/2022]
Abstract
A novel D-π-A type fluorescent probe (probe 1) was developed for water content detection in organic solvents. By analyzing the relationship between fluorescence and water content, the probe was successfully applied to determine trace water content in tetrahydrofuran, ethyl acetate, 2-butanone, acetone, dimethylformamide, and acetonitrile. High water content in THF and ethyl acetate was associated with a gradual colour change from yellowish green to earthy yellow. The red/green value had a linear relationship with the water content in THF and ethyl acetate. There was a linear relationship between the red/blue value and water content in 2-butanone and acetone. Furthermore, probe 1 could be used for human serum albumin detection. Unexpectedly, probe 1 had a different colour response in deuterated and nondeuterated solvents, and had different fluorescence intensity and fluorescence emission wavelength. Probe 1 is rare tool that can distinguish between deuterated and nondeuterated reagents.
Collapse
|
54
|
Hai H, Li H, Deng B. AB0110 TRANSCRIPTOMICS-BASED INVESTIGATION OF THE MECHANISM OF ANKYLOSING SPONDYLITIS WITH UVEITIS. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.3080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BackgroundSpondyloarthritis is a large group of autoimmune diseases that are associated with HLA-B27. Among them, Ankylosing spondylitis is a typical representative of these diseases. In addition to spine and joint involvement, AS has many extra-articular manifestations, among which uveitis is one of the most common extra-articular manifestations of AS.[1]Untreated or inappropriate treatment can lead to serious consequences such as blindness. However, there are few studies on the mechanisms of AS-related uveitis, and the pathogenesis of AS-related uveitis is not fully understood, so there is no way to prevent it.ObjectivesWe performed a whole-blood gene expression profiling and then analyzed gene expression differences between AS-associated uveitis patients and normal controls by bioinformatics methods. Protein–protein interaction network was constructed to predict the relationship among the products of the differentially expression genes (DEGs). Furthermore, module mining and function annotation were applied to assess the interaction network of DEGs.The aim is to find predictive biomarkers for AS-associated uveitis, to further discuss the pathogenesis of AS-associated uveitis in depth, and to provide a reference for clinical precision treatment.MethodsThis microarray-based discovery study used samples from three patients with AS,classified according to the New York criteria,four patients with AS-associated uveitis, and three gender- and age-matched controls. Total RNA was extracted from whole blood samples and enriched for mRNA after DNA digestion using DNase, and then constructed cDNA libraries were quality-checked with an Agilent 2100 Bioanalyzer and sequenced using an Illumina HiSeq TM 2500 sequencer.The data were normalized and initially screened for differential genes using the DESeq R package in R 4.1.0 Prediction of relationships between products of differentially expressed genes (DEGs) using String database prediction and construction of protein-protein interaction networks in Cytoscape. GO with KEGG analysis of differential genes using ClueGO and CluePedia. Screening for hub genes associated with AS-associated uveitis using cytoHubba.ResultsWe initially screened 14607 differential genes, from which 112 significantly differential genes with p-values<0.05 and |log2FC|>2 were selected. Among them, 82 were up-regulated genes and 30 were down-regulated genes. Sixty-six relationships between 49 nodes were shown in the PPI network interactions graph constructed from the String database results.The results of GO analysis showed that most genes were involved in biological processes related to immune response, such as positive regulation of inflammatory response, integrated stress response signaling and toll-like receptor 4 signaling pathway. The molecular functions were mainly focused on chemokine receptor binding. the results of KEGG analysis showed that the gene products were mainly involved in cytokine-cytokine receptor interaction, IL-17 signaling pathway. The target genes screened included CXCL8 CXCL2 NFKBIZ NFKBIA IL11 IL1A,all of which have adequate immune response effects(Figure 1)Figure 1.Using the EPC algorithm in cytoHubba to screen hub genes, the graph shows the top 10 scoring genes, with different colors representing higher scores.ConclusionWe have identified a series of genes associated with immunity in this study.These DEGs may provide a basis for insight into the pathogenesis of AS-associated uveitis. Further experimental studies are needed to confirm our hypothesis.References[1]Wenker K. J. & Quint J. M. (2021). Ankylosing Spondylitis. In StatPearls. StatPearls Publishing*Corresponding authorJing Zhu1* Bo Gong2*1Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Department of Rheumatology and Immunology Chengdu China2Department of Health Management,Sichuan Academy of Medical Sciences&Sichuan Provincial People’s Hospital,University of Electronic Science and Technology of China Chengdu ChinaDisclosure of InterestsNone declared
Collapse
|
55
|
Xu W, Liu C, Deng B, Lin P, Sun Z, Liu A, Xuan J, Li Y, Zhou K, Zhang X, Huang Q, Zhou H, He Q, Li B, Qu L, Yang J. TP53-inducible putative long noncoding RNAs encode functional polypeptides that suppress cell proliferation. Genome Res 2022; 32:1026-1041. [PMID: 35609991 DOI: 10.1101/gr.275831.121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2021] [Accepted: 05/06/2022] [Indexed: 01/10/2023]
Abstract
Polypeptides encoded by long non-coding RNAs (lncRNAs) are a novel class of functional molecules. However, whether these hidden polypeptides participate in the TP53 pathway and play a significant biological role is still unclear. Here, we discover that TP53-regulated lncRNAs encode peptides, two of which are functional in various human cell lines. Using ribosome profiling and RNA-seq approaches in HepG2 cells, we systematically identified more than 300 novel TP53-regulated lncRNAs and further confirmed that fifteen of these TP53-regulated lncRNAs encode peptides. Furthermore, several peptides were validated by multiple mass spectrometry measures. Ten of the novel translational lncRNAs were directly inducible by TP53 in response to DNA damage. Notably, we showed that the TP53-inducible peptides TP53LC02 and TP53LC04, but not their lncRNAs, could suppress cell proliferation. TP53LC04 peptide also had a function associated with cell proliferation by regulating the cell cycle in response to DNA damage. This study demonstrates that TP53-inducible lncRNAs encode new functional peptides, leading to the enlargement of the components of TP53 tumor suppressor network and providing novel potential targets for cancer therapy.
Collapse
|
56
|
Zhang Y, Deng B. PO-1838 The Comparison between DIBH and Abdominal Compression Treatment Technique in Liver SBRT. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)03801-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
57
|
Fang FT, Zhu ZY, Ge JZ, Deng B, Du JZ, Zhang J. Reconstruction of the main phytoplankton population off the Changjiang Estuary in the East China Sea and its assemblage shift in recent decades: From observations to simulation. MARINE POLLUTION BULLETIN 2022; 178:113638. [PMID: 35413505 DOI: 10.1016/j.marpolbul.2022.113638] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/24/2021] [Revised: 03/30/2022] [Accepted: 04/01/2022] [Indexed: 06/14/2023]
Abstract
Under eutrophication background, the increasing dinoflagellates blooms relative to diatoms blooms off the Changjiang Estuary has caused much concern. We have provided sediment evidence for the first time that the time window of diatoms-to-dinoflagellates shift off the Changjiang Estuary in the East China Sea is early 1990s. Investigations to the water column revealed different surface-bottom concentration matchup patterns between peridinin (dinoflagellates) and fucoxanthin (diatoms), which suggests that the diatoms-dinoflagellates shift recorded in the sediment may have come from more dinoflagellate blooms since 1990s. Physical-biogeochemical 3D numerical simulations for the past decades suggest that the effect of increasing spring sea surface temperature and increasing N/P ratio on the diatoms-dinoflagellates shift is dominant and recessive, respectively.
Collapse
|
58
|
Yuan S, Deng B, Ye Q, Wu Z, Wu J, Wang L, Xu Q, Yao L, Xu N. Excitatory neurons in paraventricular hypothalamus contributed to the mechanism underlying acupuncture regulating the swallowing function. Sci Rep 2022; 12:5797. [PMID: 35388042 PMCID: PMC8987055 DOI: 10.1038/s41598-022-09470-9] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2021] [Accepted: 03/11/2022] [Indexed: 11/20/2022] Open
Abstract
Paraventricular hypothalamus (PVH) is demonstrated to regulate stress, feeding behaviors, and other related homeostatic processes. However, no direct evidence has been investigated for the role of PVH in swallowing function. Acupuncture therapy at Lianquan (CV23) acupoint has been reported to improve the swallowing function in clinical trials, but its underlying mechanism still needs to be uncovered. Thus, we aimed to explore whether PVH involved the acupuncture mediated regulating swallowing function. Chemogenetics, electromyography (EMG) recording, and immunofluorescence staining methods were combined to demonstrate that neurons in PVH could be activated by electroacupuncture (EA) stimulation at CV23, and this neuronal cluster was represented as excitatory neurons. Furthermore, we mapped both the inputs and outputs of PVH neurons using viral tracing. The neurons in PVH projected with the brain regions, including parabrachial nucleus (PBN) and the solitary tract nucleus (NTS), which both participated in the swallowing process. The EA function regulating the swallowing was attenuated after inhibiting the neurons in PVH in the post stroke dysphagia. In conclusion, this study suggested that EA at CV23 could regulate swallowing function involving the excitatory neurons in PVH.
Collapse
|
59
|
Duan N, Guo F, Deng B, Yang S, Tian H, Sun B. Application of a luminous intensity variation fluorescent probe for the detection of ferric ions. LUMINESCENCE 2022; 37:803-809. [PMID: 35274440 DOI: 10.1002/bio.4224] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2021] [Revised: 02/25/2022] [Accepted: 03/04/2022] [Indexed: 11/06/2022]
Abstract
A luminous intensity variation fluorescent probe (Probe 1) for the detection of ferric ion was developed. The quantitative range of Fe3+ content detected was 0 to 600 μM with the LOD at 0.76 μM. Further, after 20 minutes of Fe3+ addition, the intensity of luminescence of Probe 1 solution gradually decreased with increased Fe3+ concentration. In addition, the B and G values of these images showed a linear relationship with Fe3+ concentration (0-500 μM). Probe 1 was successfully used for the rapid determination of Fe3+ concentration in real samples. This study demonstrates that Probe 1 is an excellent tool for the rapid determination of Fe3+ content in real samples using a smart phone without professional equipment.
Collapse
|
60
|
Deng B, Wang X, Luong DX, Carter RA, Wang Z, Tomson MB, Tour JM. Rare earth elements from waste. SCIENCE ADVANCES 2022; 8:eabm3132. [PMID: 35138886 PMCID: PMC8827657 DOI: 10.1126/sciadv.abm3132] [Citation(s) in RCA: 24] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/06/2023]
Abstract
Rare earth elements (REEs) are critical materials in electronics and clean technologies. With the diminishing of easily accessible minerals for mining, the REE recovery from waste is an alternative toward a circular economy. Present methods for REE recovery suffer from lengthy purifications, low extractability, and high wastewater streams. Here, we report an ultrafast electrothermal process (~3000°C, ~1 s) based on flash Joule heating (FJH) for activating wastes to improve REE extractability. FJH thermally degrades or reduces the hard-to-dissolve REE species to components with high thermodynamic solubility, leading to ~2× increase in leachability and high recovery yields using diluted acid (e.g., 0.1 M HCl). The activation strategy is feasible for various wastes including coal fly ash, bauxite residue, and electronic waste. The rapid FJH process is energy-efficient with a low electrical energy consumption of 600 kWh ton-1. The potential for this route to be rapidly scaled is outlined.
Collapse
|
61
|
She QY, Zhu Y, Chen G, Liu Y, Ruan CX, Wang Q, Sheng X, Deng B, Liang HX, Liu YT, Young CA, Qin SL. In vitro assessment of the DNA damage and senility of CD117+ stem cells collected from diabetic mice. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2022; 26:1084-1090. [PMID: 35253162 DOI: 10.26355/eurrev_202202_28097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
OBJECTIVE Angiogenesis impairment is a common feature of diabetes mellitus (DM), whereas CD117+ bone marrow cells (BMCs) injury might be responsible for such complication. In this study, we studied the effect of hyperglycemia on the DNA damage and senility of CD117+ bone marrow cells. MATERIALS AND METHODS We isolated CD117+ BMCs from the Streptozotocin (STZ) induced diabetes and healthy control mice. Oxidative stress was detected by flow cytometric analysis. γ-H2AX, which is the DNA damage mark, was detected by using Western blotting and immunofluorescence histochemistry. We also detected the expression of γ-H2AX and p16 by using Western blotting. RESULTS Compared with the control mice, the level of reactive oxygen species (ROS) was increased significantly in the CD117+ BMCs collected from the diabetic mice (p<0.05), and the percentage of γ-H2AX positive cells was higher significantly (p<0.01). The expression of γ-H2AX and p16 was increased significantly in the CD117+ BMCs from the diabetic mice. CONCLUSIONS Our experiments demonstrated the oxidative stress in CD117+ BMCs under DM conditions, while accelerating the DNA damage and senility in CD117+ BMCs as well.
Collapse
|
62
|
Bai Y, Hua B, Zhang F, Zhou W, Deng B. Effect of different intensity exercises intervention on cardiovascular functions and quality of life on patients with chronic heart failure: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2022; 101:e28554. [PMID: 35029219 PMCID: PMC8757934 DOI: 10.1097/md.0000000000028554] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/21/2021] [Accepted: 12/22/2021] [Indexed: 01/05/2023] Open
Abstract
BACKGROUND Exercise training can improve exercise capacity, quality of life, and reduce hospitalization time in chronic heart failure (CHF) patients. Various training protocols have been studied in CHF, but there is no consensus on the optimal exercise intensity for the rehabilitation of cardiac patients. Therefore, systematic evaluation of the effects of different exercise intensities on the efficacy of cardiac function and quality of life in patients with CHF was done. METHODS Computer searches of PubMed, Web of Science, The Cochrane Library, Embase, SinoMed, the China National Knowledge Infrastructure, Wanfang, and VIP databases were conducted to collect randomized controlled trials of different exercise intensities applied to patients with CHF. Study selection and data extraction will be performed simultaneously by two independent reviewers, using the PEDro scale for quality assessment of the included literature. Publication bias will be assessed by funnel plot, and Begg and Egger tests. The I2 statistic and the chi-square (χ2) test will be used to assess heterogeneity. In addition, subgroup analyses will be performed for different left ventricular ejection fraction populations and different intervention cycles. All meta-analyses will be performed using Revman5.3 software. RESULTS The present study is a systematic review and meta-analysis program with no results. Data analysis will be completed after the program has been completed. CONCLUSION This meta-analysis may provide more reliable, evidence-based evidence for the choice of exercise intensity in patients with CHF. REGISTRATION NUMBER CRD42021276529.
Collapse
|
63
|
Deng B, Chen X, Xu L, Zheng L, Zhu X, Shi J, Yang L, Wang D, Jiang D. Chordin-like 1 is a novel prognostic biomarker and correlative with immune cell infiltration in lung adenocarcinoma. Aging (Albany NY) 2022; 14:389-409. [PMID: 35021154 PMCID: PMC8791215 DOI: 10.18632/aging.203814] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2021] [Accepted: 12/29/2021] [Indexed: 11/25/2022]
Abstract
Chordin-like 1 (CHRDL1), an inhibitor of bone morphogenetic proteins(BMPs), has been recently reported to participate in the progression of numerous tumors, however, its role in lung adenocarcinoma (LUAD) remains unclear. Our study aimed to demonstrate relationship between CHRDL1 and LUAD based on data from The Cancer Genome Atlas (TCGA). Among them, CHRDL1 expression revealed promising power for distinguishing LUAD tissues form normal sample. Low CHRDL1 was correlated with poor clinicopathologic features, including high T stage (OR=0.45, P<0.001), high N stage (OR=0.57, P<0.003), bad treatment effect (OR=0.64, P=0.047), positive tumor status (OR=0.63, P=0.018), and TP53 mutation (OR=0.49, P<0.001). The survival curve illustrated that low CHRDL1 was significantly correlative with a poor overall survival (HR=0.60, P<0.001). At multivariate Cox regression analysis, CHRDL1 remained independently correlative with overall survival. GSEA identified that the CHRDL1 expression was related to cell cycle and immunoregulation. Immune infiltration analysis suggested that CHRDL1 was significantly correlative with 7 kinds of immune cells. Immunohistochemical validation showed that CHRDL1 was abnormally elevated and negatively correlated with Th2 cells in LUAD tissues. In conclusion, CHRDL1 might become a novel prognostic biomarker and therapy target in LUAD. Moreover, CHRDL1 may improve the effectiveness of immunotherapy by regulating immune infiltration.
Collapse
|
64
|
Deng B, Wang Z, Chen W, Li JT, Luong DX, Carter RA, Gao G, Yakobson BI, Zhao Y, Tour JM. Phase controlled synthesis of transition metal carbide nanocrystals by ultrafast flash Joule heating. Nat Commun 2022; 13:262. [PMID: 35017518 PMCID: PMC8752793 DOI: 10.1038/s41467-021-27878-1] [Citation(s) in RCA: 18] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2021] [Accepted: 12/13/2021] [Indexed: 01/12/2023] Open
Abstract
Nanoscale carbides enhance ultra-strong ceramics and show activity as high-performance catalysts. Traditional lengthy carburization methods for carbide syntheses usually result in coked surface, large particle size, and uncontrolled phase. Here, a flash Joule heating process is developed for ultrafast synthesis of carbide nanocrystals within 1 s. Various interstitial transition metal carbides (TiC, ZrC, HfC, VC, NbC, TaC, Cr2C3, MoC, and W2C) and covalent carbides (B4C and SiC) are produced using low-cost precursors. By controlling pulse voltages, phase-pure molybdenum carbides including β-Mo2C and metastable α-MoC1-x and η-MoC1-x are selectively synthesized, demonstrating the excellent phase engineering ability of the flash Joule heating by broadly tunable energy input that can exceed 3000 K coupled with kinetically controlled ultrafast cooling (>104 K s-1). Theoretical calculation reveals carbon vacancies as the driving factor for topotactic transition of carbide phases. The phase-dependent hydrogen evolution capability of molybdenum carbides is investigated with β-Mo2C showing the best performance.
Collapse
|
65
|
Yin S, Zhao P, Ai Z, Deng B, Jia W, Wang H, Zheng J. Sex-specific differences in blood lipids and lipid ratios in type 2 diabetic foot patients. J Diabetes Investig 2021; 12:2203-2211. [PMID: 34137504 PMCID: PMC8668058 DOI: 10.1111/jdi.13615] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/16/2020] [Revised: 05/27/2021] [Accepted: 06/10/2021] [Indexed: 01/13/2023] Open
Abstract
AIMS/INTRODUCTION Few people have reported whether there are sex differences in blood lipids and lipid ratios in type 2 diabetic foot (T2DF) patients in China. This study attempts to identify the contribution to sex-specific differences in blood lipids and lipid ratios in these patients. MATERIALS AND METHODS In this case-control study, we explore 306 patients with T2DF as the study group and 306 patients with type 2 diabetes mellitus as the control group. Patients were diagnosed according to the Standards of Medical Care in Diabetes-2014 (American Diabetes Association). Blood lipid and lipid ratios were determined according to the National Cholesterol Education Program Adult Treatment Panel III criteria. RESULTS We studied male patients with T2DF who were aged 68.00 years (18.00 years) and females who were aged 73.50 years (19.00 years); 61.76% of the patients were men. Men had higher body mass index and glycated hemoglobin levels than women. Compared with type 2 diabetes mellitus patients, T2DF patients had significant differences in total cholesterol/high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol/HDL-C and apolipoprotein (apo)B/apoA-I ratios. HDL-C, triglyceride, apoA-I and apoB/apoA-I ratio showed cardiovascular disease risk in men, whereas total cholesterol, low-density lipoprotein cholesterol, apoB, and the low-density lipoprotein cholesterol/HDL-C and total cholesterol/HDL-C ratios were better predictors in women. The apoB/apoA-I ratio odds ratio values were 2.18 (95% confidence interval 1.17-4.41) and 2.14 (95% confidence interval 1.14-4.00) in male patients with T2DF before and after adjusting for age, respectively (P < 0.05). CONCLUSIONS T2DF patients present sex-specific differences in their blood lipid and lipid ratios, especially in the apoB/apoA-I ratio, which could be a better indicator for cardiovascular disease risk.
Collapse
|
66
|
Zhan Y, Deng B, Wu H, Xu C, Wang R, Li W, Pan Z. Biomineralized Composite Liquid Crystal Fiber Scaffold Promotes Bone Regeneration by Enhancement of Osteogenesis and Angiogenesis. Front Pharmacol 2021; 12:736301. [PMID: 34819856 PMCID: PMC8606401 DOI: 10.3389/fphar.2021.736301] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2021] [Accepted: 10/15/2021] [Indexed: 11/29/2022] Open
Abstract
Liquid crystals (LCs) are appealing biomaterials for applications in bone regenerative medicine due to their tunable physical properties and anisotropic viscoelastic behavior. This study reports a novel composite poly (L-lactide) (PLLA) scaffold that is manufactured by a simple electrospinning and biomineralization technique that precisely controls the fibrous structure in liquid LC phase. The enriched-LC composites have superior mineralization ability than neat PLLA; furthermore BMSC cells were inoculated onto the HAP-PLLA/LC with hydroxyapatite (HAP) composite scaffold to test the capability for osteogenesis in vitro. The results show that the PLLA/LC with HAP produced by mineralization leads to better cell compatibility, which is beneficial to cell proliferation, osteogenic differentiation, and expression of the angiogenic CD31 gene. Moreover, in vivo studies showed that the HAP-PLLA/LC scaffold with a bone-like environment significantly accelerates new and mature lamellar bone formation by development of a microenvironment for vascularized bone regeneration. Thus, this bionic composite scaffold in an LC state combining osteogenesis with vascularized activities is a promising biomaterial for bone regeneration in defective areas.
Collapse
|
67
|
Xiao Y, Wang X, Yang J, Liu K, Li M, Ma Z, Deng B, Shen L, Wei Y, Zhang S, Zhang N, Zhao P, Zhu C, Mao M, Tang N, Wu Q. Huatan Dingji Decoction intervening in atrial fibrillation: protocol for a randomized double-blind single-simulated placebo-controlled clinical trial. Trials 2021; 22:693. [PMID: 34635144 PMCID: PMC8504014 DOI: 10.1186/s13063-021-05522-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2021] [Accepted: 08/06/2021] [Indexed: 12/04/2022] Open
Abstract
Background Atrial fibrillation (AF) is one of the most common cardiac arrhythmias and can lead to heart failure (HF), stroke, pulmonary embolism (PE), and other complications, seriously affecting people’s quality of life and health. Western medicine is limited in the treatment of AF, while Traditional Chinese Medicine (TCM) has unique advantages, such as less side effects, low toxicity, long effect duration, and high compliance. The prescription of HTDJ is a common prescription for the treatment of atrial fibrillation in Longhua Hospital, Shanghai University of Traditional Chinese Medicine. It has been used for many years and has a large number of clinically effective cases. It has a good clinical application prospect, but there is a lack of effective evaluation of its clinical efficacy. Method This study adopts a randomized double-blind, single-simulated, placebo-controlled research method. Participants were randomly assigned in a 1:1 ratio through a centrally controlled, computer-generated, simple randomization schedule. Participants would take the medicine for 1 month, and the curative effect would be evaluated. Subsequently, the participants would not take TCM and only receive western medicine treatment. They would be followed up for another 8 weeks, and a clinical evaluation would be conducted. The secondary outcomes include echocardiography, Hamilton Anxiety Scale, Hamilton Depression Scale, rate of increase and decrease of anti-arrhythmia western medicine, the MOS 36-item short-form health survey, N-terminal-pro hormone B-type natriuretic peptide level, and integral TCM syndrome score. Adverse events will be monitored throughout the trial. Cases are from outpatient and inpatient with atrial fibrillation in the Cardiology Department of Longhua Hospital. Evaluations will be conducted at baseline and at weeks 4 and 12 after randomization. Discussion In this study, the efficacy and safety of HTDJ plus western medicine in the treatment of atrial fibrillation (qi deficiency and phlegm opacities) will be evaluated, so as to provide medical evidence of short-term and medium-term clinical efficacy for the treatment of atrial fibrillation with integrated traditional and western medicine and lay a foundation for further clinical development and application. Trial registration ClinicalTrials.govChiCTR2000030517. Registered on March 5, 2020, with the Chinese Clinical Trial Registry
Collapse
|
68
|
Deng B, Luong DX, Wang Z, Kittrell C, McHugh EA, Tour JM. Urban mining by flash Joule heating. Nat Commun 2021; 12:5794. [PMID: 34608143 PMCID: PMC8490403 DOI: 10.1038/s41467-021-26038-9] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2021] [Accepted: 09/07/2021] [Indexed: 11/09/2022] Open
Abstract
Precious metal recovery from electronic waste, termed urban mining, is important for a circular economy. Present methods for urban mining, mainly smelting and leaching, suffer from lengthy purification processes and negative environmental impacts. Here, a solvent-free and sustainable process by flash Joule heating is disclosed to recover precious metals and remove hazardous heavy metals in electronic waste within one second. The sample temperature ramps to ~3400 K in milliseconds by the ultrafast electrical thermal process. Such a high temperature enables the evaporative separation of precious metals from the supporting matrices, with the recovery yields >80% for Rh, Pd, Ag, and >60% for Au. The heavy metals in electronic waste, some of which are highly toxic including Cr, As, Cd, Hg, and Pb, are also removed, leaving a final waste with minimal metal content, acceptable even for agriculture soil levels. Urban mining by flash Joule heating would be 80× to 500× less energy consumptive than using traditional smelting furnaces for metal-component recovery and more environmentally friendly.
Collapse
|
69
|
Li Y, Deng B, Yang S, Tian H, Sun B. A colorimetric fluorescent probe for the detection of tyrosinase and its application for the food industry. J Photochem Photobiol A Chem 2021. [DOI: 10.1016/j.jphotochem.2021.113458] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
|
70
|
Zhang Z, Zeng D, Zhang W, Chen A, Lei J, Liu F, Deng B, Zhuo J, He B, Yan M, Lei X, Wang S, Lam EWF, Liu Q, Wang Z. Modulation of oxidative phosphorylation augments antineoplastic activity of mitotic aurora kinase inhibition. Cell Death Dis 2021; 12:893. [PMID: 34593753 PMCID: PMC8484571 DOI: 10.1038/s41419-021-04190-w] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2021] [Revised: 09/06/2021] [Accepted: 09/17/2021] [Indexed: 02/08/2023]
Abstract
Uncontrolled mitosis is one of the most important features of cancer, and mitotic kinases are thought to be ideal targets for anticancer therapeutics. However, despite numerous clinical attempts spanning decades, clinical trials for mitotic kinase-targeting agents have generally stalled in the late stages due to limited therapeutic effectiveness. Alisertib (MLN8237) is a promising oral mitotic aurora kinase A (AURKA, Aurora-A) selective inhibitor, which is currently under several clinical evaluations but has failed in its first Phase III trial due to inadequate efficacy. In this study, we performed genome-wide CRISPR/Cas9-based screening to identify vulnerable biological processes associated with alisertib in breast cancer MDA-MB-231 cells. The result indicated that alisertib treated cancer cells are more sensitive to the genetic perturbation of oxidative phosphorylation (OXPHOS). Mechanistic investigation indicated that alisertib treatment, as well as other mitotic kinase inhibitors, rapidly reduces the intracellular ATP level to generate a status that is highly addictive to OXPHOS. Furthermore, the combinational inhibition of mitotic kinase and OXPHOS by alisertib, and metformin respectively, generates severe energy exhaustion in mitotic cells that consequently triggers cell death. The combination regimen also enhanced tumor regression significantly in vivo. This suggests that targeting OXPHOS by metformin is a potential strategy for promoting the therapeutic effects of mitotic kinase inhibitors through the joint targeting of mitosis and cellular energy homeostasis.
Collapse
|
71
|
Li Y, Deng B, Yang S, Tian H, Liu Y, Sun B. A Fluorescent Probe for The Visible Colorimetric Detection of Tyrosinase. ChemistrySelect 2021. [DOI: 10.1002/slct.202102473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
72
|
Huang J, Deng B, Shuai J, Zhao S, Qiu Y. Effect of different routes of administration on early cognitive function following inguinal hernia repair. Am J Transl Res 2021; 13:7882-7889. [PMID: 34377266 PMCID: PMC8340168] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2020] [Accepted: 04/23/2021] [Indexed: 06/13/2023]
Abstract
PURPOSE To analyze the effects of different routes of dexmedetomidine administration on early cognitive function following inguinal hernia repair. METHODS A total of 83 patients with pediatric inguinal hernias admitted to our hospital from January 2018 to October 2020 were divided into control group (CNG, n = 41) and observation group (OG, n = 42) by random number table. The OG was given 2 μg/kg of dexmedetomidine hydrochloride by intranasal administration, and the CNG was treated with 0.5 μg/kg of dexmedetomidine hydrochloride via intravenous (IV) infusion pump. The hemodynamics, condition of anesthesia, awakening, and safety were compared between the two groups. RESULTS Systolic blood pressure and oxygen saturation levels at T1 and T2 in the OG were not different from those in the CNG (P > 0.05), and heart rates in the OG were all higher than those in the CNG (P < 0.05). The incidence of emergence agitation during awakening was 4.76% in the OG, which was lower than 21.95% compared with the CNG (P < 0.05). Ramsay sedation scores at 15 and 30 min after awakening in the OG were higher than those in the CNG, and PAED scores in the OG were lower than those in the CNG (P < 0.05). Cognitive, language, and motor scores in the OG were higher than those in the CNG at 3 days after surgery (P < 0.05), and the incidence of cognitive dysfunction was 4.76% in the OG at 3 days after surgery, which was lower compared with 21.95% in the CNG (P < 0.05). CONCLUSION Application of dexmedetomidine hydrochloride by intranasal administration or intravenous infusion before induction can ensure rapid postoperative awakening of the children without causing significant fluctuations in blood pressure and oxygen saturation, and both methods have a high safety profile. However, intranasal administration results in more satisfactory sedation, less postoperative agitation upon awakening, and reduces postoperative cognitive dysfunction.
Collapse
|
73
|
Chen X, Zhang S, Hou D, Duan H, Deng B, Zeng Z, Liu B, Sun L, Song R, Du J, Gao P, Peng H, Liu Z, Wang L. Tunable Pore Size from Sub-Nanometer to a Few Nanometers in Large-Area Graphene Nanoporous Atomically Thin Membranes. ACS APPLIED MATERIALS & INTERFACES 2021; 13:29926-29935. [PMID: 34133124 DOI: 10.1021/acsami.1c06243] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Membranes are key components in chemical purification, biological separation, and water desalination. Traditional polymeric membranes are subjected to a ubiquitous trade-off between permeance and selectivity, which significantly hinders the separation performance. Nanoporous atomically thin membranes (NATMs), such as graphene NATMs, have the potential to break this trade-off. Owing to their uniqueness of two-dimensional structure and potential nanopore structure controllability, NATMs are expected to have outstanding selectivity through molecular sieving while achieving ultimate permeance at the same time. However, a drastic selectivity discrepancy exists between the proof-of-concept demonstrations and scalable separation applications in graphene membranes. In this paper, we offer a possible solution to narrow this discrepancy by tuning the pore density and pore size separately with two successive plasma treatments. We demonstrate that by narrowing the pore size distribution, the selectivity of graphene membranes can be greatly increased. Low-energy argon plasma is first applied to nucleate high density of defects in graphene. Controlled oxygen plasma is then utilized to selectively enlarge the defects into nanopores with desired sizes. This method is scalable, and the fabricated 1 cm2 graphene NATMs with sub-nanometer pores can separate KCl and Allura Red with a selectivity of 104 and a permeance of 1.1 × 10-6 m s-1. The pores in NATMs can be further tuned from gas-selective sub-nanometer pores to a few nanometer size. The fabricated NATMs show a selectivity of 35 between CO2 and N2. With longer enlargement time, a selectivity of 21.2 between a lysozyme and bovine serum albumin can also be achieved with roughly four times higher permeance than that of a commercial dialysis membrane. This research offers a solution to realize NATMs of tunable pore size with a narrow pore size distribution for different separation processes from sub-nanometer in gas separation or desalination to a few nanometers in dialysis.
Collapse
|
74
|
Wang W, Li T, Chen Q, Deng B, Deng L, Zeng K. Transcription Factor CsWRKY65 Participates in the Establishment of Disease Resistance of Citrus Fruits to Penicillium digitatum. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2021; 69:5671-5682. [PMID: 33988021 DOI: 10.1021/acs.jafc.1c01411] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/14/2023]
Abstract
Penicillium digitatum is the primary pathogen that causes serious yield losses worldwide. In our previous study, CsWRKY transcription factors (TFs) and some genes associated with immunity were identified in citrus fruits after P. digitatum infection, but little information is available in the literature on the mechanisms of TFs in citrus disease resistance. In this study, the possible mechanisms of CsWRKY65 participating in the establishment of disease resistance were investigated. Results show that CsWRKY65 was a transcriptional activator in the nucleus. The dual-luciferase transient assays and electrophoretic mobility shift assays showed that CsWRKY65 bound with CsRbohB, CsRbohD, CsCDPK33, and CsPR10 promoters to activate gene transcription. Besides, the transient overexpression of CsWRKY65 induced reactive oxygen species accumulation and increased PR gene expression in Nicotiana benthamiana leaves. The transient overexpression of CsWRKY65 in the citrus peel enhanced the disease resistance against P. digitatum. In conclusion, CsWRKY65 is likely to be involved in regulating the disease resistance to P. digitatum of citrus fruits by directly activating the expressions of CsRbohB, CsRbohD, CsCDPK33, and CsPR10. This study provides new information for the mechanism of citrus WRKY TFs participating in the establishment of disease resistance.
Collapse
|
75
|
Zhang N, Zhao Y, Liu Y, Tang N, Zheng W, Mao M, Liu Q, Shen L, Deng B. A double-blinded, placebo-controlled randomized trial evaluating the efficacy and safety of Zhigancao Tang granules for treating HFpEF: study protocol for a randomized controlled trial. Trials 2021; 22:293. [PMID: 33879223 PMCID: PMC8056488 DOI: 10.1186/s13063-021-05232-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2020] [Accepted: 03/29/2021] [Indexed: 12/13/2022] Open
Abstract
BACKGROUND Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome characterized by diastolic dysfunction. Despite the increasing incidence of HFpEF, there is no available therapy that reduces the mortality rate of HFpEF. Zhigancao Tang has been used traditionally for the treatment of cardiovascular diseases in China. The use of traditional Chinese medicine (TCM) is associated with improvements in clinical syndromes and quality of life of patients. A randomized clinical trial should be conducted to provide clear evidence regarding the efficacy and safety of Zhigancao Tang granules for the treatment of HFpEF. METHODS A randomized, double-blinded, placebo-controlled clinical trial was proposed. A total of 122 patients with HFpEF will be randomly assigned to receive Zhigancao Tang granules or placebo for 12 weeks. The primary outcome measure is cardiac function. The secondary outcomes include measurement of the integral TCM syndrome score, echocardiography, 6-min walk test, N-terminal-pro hormone B-type natriuretic peptide level, atrial natriuretic peptide level, Minnesota Living with Heart Failure scale, and Lee's scale. The outcome measures will be evaluated at baseline, 4 weeks, and 12 weeks. Adverse events will be evaluated from baseline till the 12-week follow-up period. DISCUSSION The results of this trial will demonstrate whether Zhigancao Tang granules are effective and safe for treating HFpEF. TRIAL REGISTRATION ClinicalTrials.gov NCT04317339 . Registered on 23 March 2020.
Collapse
|